Amicus Therapeutics

Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals
Xconomy
Sun, 08/12/18 - 01:20 pm
Fabry disease
FDA
Amicus Therapeutics
Galafold
2 Biotech Acquisition Candidates That Could Be Next in M&A Crosshairs
TheStreet.com
Mon, 01/29/18 - 09:29 am
biotech
M&A
Bluebird Bio
Amicus Therapeutics
Prescribed Reading: DMD, MS and other acronyms
Biopharma Dive
Sun, 10/8/17 - 11:22 am
Celgene
Nimbus
Endocyte
Amicus Therapeutics
Catabasis
Motif Biosciences
Amicus’ latest positive update on Pompe drug hints at accelerated approval pitch
Endpoints
Wed, 10/4/17 - 11:15 am
Amicus Therapeutics
Pompe disease
ATB200/AT2221
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002
Signaling a major shift at the FDA, regulators put Amicus’ once-spurned drug on fast track
Endpoints
Tue, 09/19/17 - 09:22 am
FDA
Amicus Therapeutics
migalastat
Fabry disease
fast track
FDA Reverses Decision, Allowing Amicus To File For Rare Disease Drug
Forbes
Tue, 07/11/17 - 09:53 am
FDA
Amicus Therapeutics
Rare Diseases
Fabry disease
migalastat
Are These 2 Biotechs Diamonds in the Rough?
Motley Fool
Thu, 03/16/17 - 10:03 pm
biotech
Amicus Therapeutics
Adamas Pharmaceuticals
ADS-5102
Galafold
Biotechs Breaking Out On Drug Development News
Forbes
Fri, 03/3/17 - 09:21 am
Bluebird Bio
Esperion Therapeutics
Amicus Therapeutics
Kite Pharma
Four biotech stocks surging on optimism about drug trials, product launches
Marketwatch
Thu, 03/2/17 - 03:43 pm
clinical trials
Bluebird Bio
Amicus Therapeutics
Kite Pharma
NeuroDerm
4 Biopharma Stocks Moving the Market on Wednesday
Yahoo/24-7 Wall St
Wed, 03/1/17 - 08:57 pm
Skyline Medical
Dynavax Technologies
Amicus Therapeutics
Pacira
These Small Biotechs Are Poised to Go Higher
Investopedia
Thu, 02/23/17 - 09:20 am
biotech
Blood Therapeutics
Versartis
Amicus Therapeutics
Key FDA Decision And Trial Dates In February
Seeking Alpha
Mon, 01/30/17 - 11:03 pm
FDA
Amgen
Valeant Pharmaceuticals
Amphastar
Egalet
Lexicon Pharmaceuticals
Amicus Therapeutics
Axovant
FDA Requests Additional Data on Amicus’ Fabry Disease Treatment
Yahoo/24-7 Wall St
Tue, 11/29/16 - 05:33 pm
Fabry disease
FDA
Amicus Therapeutics
5 Small-Cap Biotechs With Big Potential
TheStreet.com
Mon, 08/1/16 - 09:26 am
biotech
Portola Pharmaceuticals
Progenics
Redhill Biopharma
Dynavax
Amicus Therapeutics
Amicus' Fabry disease drug gets European Commission approval
Yahoo/Reuters
Tue, 05/31/16 - 09:52 am
Amicus Therapeutics
Fabry's disease
Europe
migalastat
Amicus, Other Biotech CEOs Should Listen More, Talk Less About FDA Matters
TheStreet.com
Fri, 10/2/15 - 04:55 pm
Amicus Therapeutics
FDA
Amicus Acquires Scioderm, Adds Drug for Rare Skin Disorder to Pipeline
TheStreet.com
Mon, 08/31/15 - 08:23 am
Amicus Therapeutics
Scioderm
M&A
5 Drugs That Investors May Be Undervaluing
Motley Fool
Mon, 07/13/15 - 11:04 am
Amicus Therapeutics
Galafold
Receptos
ozanimod
GS-5816
Gilead Sciences
ACH-3102
Achillion
Ophthotech
Fovista
Amicus Jumps to Seven-Year High After $225 Million Share Sale
Bloomberg
Mon, 06/15/15 - 09:32 am
Amicus Therapeutics

Pages